🔗 Share this article

The prestigious award in medical science was awarded for transformative discoveries that clarify how the immune system targets harmful pathogens while sparing the healthy tissues.

Three renowned scientists—from Japan Shimon Sakaguchi and US scientists Mary Brunkow and Dr. Ramsdell—received this honor.

The work uncovered specialized "security guards" within the immune system that remove malfunctioning defense cells capable of attacking the body.

These findings are now paving the way for innovative therapies for autoimmune diseases and malignancies.

These laureates will share a prize fund worth 11m Swedish kronor.

Crucial Findings

"The research has been essential for comprehending how the immune system functions and why we do not all develop serious autoimmune diseases," stated the chair of the award panel.

This team's studies address a core question: In what way does the defense system protect us from countless invaders while leaving our own tissues intact?

The immune system employs immune cells that search for signs of disease, including pathogens and germs it has not met before.

Such defenders utilize detectors—called receptors—that are generated by chance in countless combinations.

This provides the defense network the capacity to combat a broad range of invaders, but the randomness of the mechanism inevitably produces immune cells that may target the host.

Security Guards of the Immune System

Scientists previously knew that some of these harmful defense cells were destroyed in the immune organ—the site where white blood cells develop.

The latest Nobel Prize honors the discovery of regulatory T-cells—described as the body's "peacekeepers"—which travel through the body to neutralize any immune cells that attack the healthy cells.

It is known that this process malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA.

The Nobel panel added, "The findings have established a novel area of investigation and accelerated the creation of new treatments, for example for tumors and autoimmune diseases."

In cancer, T-regs block the system from attacking the tumor, so research are focused on lowering their numbers.

For self-attack disorders, trials are testing boosting T-reg cells so the body is no longer under attack. A similar approach could also be useful in minimizing the chances of transplanted organ failure.

Pioneering Studies

Professor Sakaguchi, from Osaka University, conducted experiments on rodents that had their immune gland removed, leading to self-attack conditions.

The researcher demonstrated that introducing immune cells from healthy mice could prevent the illness—implying there was a mechanism for blocking immune cells from attacking the host.

Dr. Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were studying an inherited autoimmune disease in mice and humans that led to the identification of a genetic factor vital for the way T-regs function.

"Their pioneering work has revealed how the body's defenses is kept in check by T-reg cells, preventing it from accidentally targeting the healthy cells," commented a prominent physiology expert.

"This research is a striking example of how basic biological study can have broad consequences for human health."